CTOs on the Move

Vanda Pharmaceuticals

www.vandapharmaceuticals.com

 
Vanda Pharmaceuticals (NASDAQ: VNDA) is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders to address unmet needs. The company has assembled an experienced team along with a portfolio of clinical and commercial stage programs with the goal of bringing important new treatment options to patients.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

PINNACLE CBO

PINNACLE CBO is a Lakewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BioMedica Diagnostics

BioMedica Diagnostics Inc. is a Windsor, NS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Retire-At-Home Services Inc

Retire-At-Home Services Inc is a Ottawa, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ASCENDIS PHARMA

Ascendis Pharma is focused on creating drug candidates that are improved versions of existing drugs, yielding more effective, lower-risk drugs with new patent life. Our proprietary TransCon platform is the leading, most versatile transient conjugation technology and is utilized to create clinically superior prodrugs in therapeutic areas characterized by high unmet medical need. TransCon technology creates novel long acting prodrugs of proteins, peptides and small molecules, suitable for either local or systemic treatment. Ascendis Pharma has a diversified and balanced high-value pipeline, including internal programs and partnerships together with market leaders on their key projects.

Immune Design

Immune Design is a clinical-stage immunotherapy company employing next-generation in vivo approaches designed to enable the body`s immune system to fight disease. The company`s technologies are engineered to activate the immune system`s natural ability to create tumor-specific cytotoxic T cells to fight cancer and other chronic disease. Immune Design`s clinical programs are the product of its two synergistic platforms: DCVexTM and GLAASTM.